Vivo Capital VIII, LLC

CIK 1618789 · last filed 2023-12-19

Vivo Capital VIII, LLC is a corporate insider who has filed 10 SEC Form 4 insider transactions across 6 companies since 2017. Across all open-market trades the lifetime net is −$20.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$17.67M

Companies

6

Total Filings

10

Lifetime Open-Market Net

-$20.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BOLT	10%+ Owner	7,179	$4.05	$29.1K	-$559.5K	1	2023-11-20
Terns Pharmaceuticals, Inc. (TERN) Delisted	10%+ Owner	281,223	$52.95	$14.89M	$27.50M	1	2022-12-23
IPI Legacy Liquidation Co (IMPL) Delisted	10%+ Owner	—	$0.24	—	$0	1	2021-04-26
Timber Pharmaceuticals, Inc. (BPMX) Delisted	10%+ Owner	26,439	—	—	-$1.11M	4	2019-06-27
CRNX	10%+ Owner	210,373	$83.85	$17.64M	-$46.39M	1	2019-03-25
Nabriva Therapeutics plc (NBRV) Delisted	10%+ Owner	1,977	$1.42	$2.8K	$497.9K	1	2017-09-18

Recent Filings

10 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-12-19	—	Sell (S)	−1,725,000	-$222.4K
2023-11-20	BOLT	Sell (S)	−602,378	-$559.5K	EDGAR
2022-12-23	Terns Pharmaceuticals, Inc. (TERN) Delisted	Buy (P)	+3,793,100	$27.50M	EDGAR
2021-04-26	IPI Legacy Liquidation Co (IMPL) Delisted	Other (J)	—	$0	EDGAR
2019-06-27	Timber Pharmaceuticals, Inc. (BPMX) Delisted	Sell (S)	−327,870	-$334.4K	EDGAR
2019-03-25	CRNX	Sell (S)	−2,085,000	-$46.39M	EDGAR
2018-03-09	Timber Pharmaceuticals, Inc. (BPMX) Delisted	Sell (S)	−2,000,000	-$720.0K	EDGAR
2018-01-31	Timber Pharmaceuticals, Inc. (BPMX) Delisted	Conv (C)	+4,328,571	$0	EDGAR
2017-11-13	Timber Pharmaceuticals, Inc. (BPMX) Delisted	Sell (S)	−296,394	-$59.3K	EDGAR
2017-09-18	Nabriva Therapeutics plc (NBRV) Delisted	Buy (P)	+52,631	$497.9K	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.